TCF3::PBX1 + mouse leukemias show consistent loss of tumor-suppressor genes (PAX5 and CDKN2A/2B) and activation of signaling pathways by point mutations (JAK/STAT, RAS/MAPK). This evidence concerns the gene TCF3 and leukemia.